In yesterday’s Wall Street session, Senseonics Holdings Inc. (AMEX:SENS) shares traded at $0.92, down -12.70% from the previous session.
As of this writing, 5 analysts cover Senseonics Holdings Inc. (AMEX:SENS). The consensus rating among analysts is ‘Hold’. SENS stock price is now 20.16% away from the 50-day moving average and -3.32% away from the 200-day moving average. The market capitalization of the company currently stands at $457.67M.
There are 1 analysts who have given it a hold rating, whereas 2 have given it a buy rating.
With the price target of $0.50, Jefferies recently initiated with Underperform rating for Senseonics Holdings Inc. (AMEX: SENS).
In other news, JAIN Mukul, Chief Operating Officer sold 50,000 shares of the company’s stock on Aug 04. The stock was sold for $98,500 at an average price of $1.97. Upon completion of the transaction, the Chief Operating Officer now directly owns 2,506,156 shares in the company, valued at $2.31 million. Insiders disposed of 2,287,377 shares of company stock worth roughly $2.1 million over the past 1 year. A total of 1.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SENS stock. A new stake in Senseonics Holdings Inc. shares was purchased by SIMPLICITY SOLUTIONS, LLC during the first quarter worth $13,000. GUGGENHEIM CAPITAL LLC invested $11,000 in shares of SENS during the first quarter. In the first quarter, PRIVATE ADVISOR GROUP, LLC acquired a new stake in Senseonics Holdings Inc. valued at approximately $10,000. SEI INVESTMENTS CO acquired a new stake in SENS for approximately $9,000. CORECAP ADVISORS, LLC purchased a new stake in SENS valued at around $3,000 in the second quarter. In total, there are 237 active investors with 27.50% ownership of the company’s stock.
Wednesday morning saw Senseonics Holdings Inc. (AMEX: SENS) opened at $1.0500. During the past 12 months, Senseonics Holdings Inc. has had a low of $0.54 and a high of $2.44. As of last week, the company has a debt-to-equity ratio of 0.58, a current ratio of 10.20, and a quick ratio of 9.70. According to the stock market information, the enterprise value for the company is $352.12M, which is based on a 13.89 price-to-earnings ratio, a 0.43 price-to-earnings-growth ratio, and a beta of 0.96. The fifty day moving average price for SENS is $0.7689 and a two-hundred day moving average price translates $0.9456 for the stock.
The latest earnings results from Senseonics Holdings Inc. (AMEX: SENS) was released for Mar, 2023. According to the Medical Devices Company, earnings per share came in at $0, beating analysts’ expectations of -$0.03 by 0.03. This compares to $0.14 EPS in the same period last year. The company reported revenue of $4.14 million for the quarter, compared to $2.48 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 66.75 percent. For the current quarter, analysts expect SENS to generate $4.51M in revenue.
Senseonics Holdings Inc.(SENS) Company Profile
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
